Concepedia
Statistics
Publications
47
Citations
5.6K
H-Index
30
Active since
2004
Affiliations
Dana-Farber Cancer Institute(Current)
Brigham and Women's Hospital
Harvard University
Massachusetts General Hospital
The University of Texas MD Anderson Cancer Center
Hongfang Wang is an author at Dana-Farber Cancer Institute specializing in medicine, life sciences, and molecular oncology.
Publications per year
2004–2024
Durable Remissions with Ivosidenib in <i>IDH1</i> -Mutated Relapsed or Refractory AML
Courtney D. DiNardo, Eytan M. Stein, Stéphane de Botton et al. · New England Journal of Medicine · 2018 · 1.4K citations · Full text
Medicine, Pharmacology, Pharmacotherapy +13
An epigenetic mechanism of resistance to targeted therapy in T cell acute lymphoblastic leukemia
Birgit Knoechel, Justine E. Roderick, Kaylyn E. Williamson et al. · Nature Genetics · 2014 · 382 citations · Full text
Medicine, Molecular Biology, Oncology +16
Ivosidenib induces deep durable remissions in patients with newly diagnosed IDH1-mutant acute myeloid leukemia
Gail J. Roboz, Courtney D. DiNardo, Eytan M. Stein et al. · Blood · 2019 · 375 citations · Full text
Medicine, Hematology, Pharmacology +12
NOTCH1–RBPJ complexes drive target gene expression through dynamic interactions with superenhancers
Hongfang Wang, Chongzhi Zang, Len Taing et al. · Proceedings of the National Academy of Sciences · 2013 · 266 citations · Full text
Life Sciences, Genetics, Molecular Biology +17
Genome-wide analysis reveals conserved and divergent features of Notch1/RBPJ binding in human and murine T-lymphoblastic leukemia cells
Hongfang Wang, James Zou, Bo Zhao et al. · Proceedings of the National Academy of Sciences · 2011 · 241 citations
1–5 of 47